GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.
from Reuters: South Asia News https://ift.tt/2mLpRNT
No comments:
Post a Comment